Updated NAV on SK Inc Post 660 Billion Pre-IPO Investment in SK Pharmteco

Dec 30, 2023

∙ Paid

It was reported on 27 December that SK Pharmteco completed a 660 billion won in pre-IPO funding valuing the company at 4 trillion won.
Prior to this investment, SK Inc owned a 100% stake in SK Pharmteco. After this investment, it is estimated that SK Inc will own about 83.5% stake in SK Pharmteco.
Our base case valuation of SK Inc is NAV of 19.0 trillion won (NAV per share of 258,967 won), representing a 47% upside from current levels.

Keep reading with a 7-day free trial

Subscribe to Douglas Research Insights to keep reading this post and get 7 days of free access to the full post archives.